
The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its third quarter 2026 financial results after market on Monday, No…
CC is up 0.47% today. Volume is 1.90M vs a 30-day average of 2.13M (0.90x).
Chemours Company (The) is scheduled to report earnings Mon, Nov 2, 2026 · after close. Analysts expect EPS of $0.28 on revenue of about $1.59B. Stocks often move sharply on earnings day.

The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its third quarter 2026 financial results after market on Monday, No…

Chemours is facing a securities class action lawsuit filed in the U.S. District Court for the District of Delaware over alleged misstatements about Opteon demand and 2026 financia…
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $24 to $20.

The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company, today announces that it has taken action to protect its intellectual property relating to refrigerant tec…

Analysts downgraded CTNM, CC, ACI, BRKR and SAFE; targets fell for CTNM, CC and ACI, while BRKR received a new $60 target.